Treatment of autism and similar disorders
View Patent ↗Methods of treating certain behavioral characteristics associated with autism are provided. Additionally, methods of treating disorders associated with repetitive behaviors, social deficits and/or cognitive deficits are also provided. A therapeutic amount of oxytocin or oxytocin analogs, either alone or in combination, are administered to individuals demonstrating behavioral characteristics associated with autism or other disorders to reduce the severity of the debilitating behavior. In various aspects, characteristics such as deficit in social awareness or cognitive skills and repetitive behaviors are treated. Co-administration of oxytocin and/or oxytocin analogs with known psychopharmacologic agents is also provided. Advantageously, oxytocin and oxytocin analogs do not have deleterious effects with other drugs such that administration results in few side effects.
1. In a method for treatment of an individual with autism, by administration of a psychopharmacologic agent, the improvement comprising:
additional administration of a therapeutically effective amount of a composition comprising oxytocin having the formula,
wherein the psychopharmacologic agent is selected from the group consisting of sedatives, tranquilizers, antipsychotics, antidepressants, and anticonvulsants; and
wherein the psychopharmacologic agent and the additional composition are administered within about 6-24 hours of each other.
2. The method of claim 1 , wherein said therapeutically effective amount ranges from 0.1 unit per hour to 7 units per hour.
3. In a method for treatment of an individual with an autism spectrum disorder by administration of a psychopharmacologic agent, the improvement comprising:
additional administration of a therapeutically effective amount of a composition, comprising oxytocin having the formula,
wherein the psychopharmacologic agent is selected from the group consisting of sedatives, tranquilizers, antipsychotics, antidepressants, and anticonvulsants; and
wherein the psychopharmacologic agent and the additional composition are administered within about 6-24 hours of each other.
4. The method of claim 3 , wherein said therapeutically effective amount is 10 units per ml oxytocin dissolved into 1000 mL normal saline, administered at a rate of 10 milliunits per minute or 6 units/hour.